| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 08/09/21 | 07:00:06 | 8 Sept 2021 | Phase I MSA contract award worth >$500k | RNS | |
| 06/08/21 | 07:00:03 | 6 Aug 2021 | Trading Update | RNS | |
| 23/06/21 | 15:32:31 | 23 Jun 2021 | Issue of Equity | RNS | |
| 21/06/21 | 14:31:16 | 21 Jun 2021 | Holding(s) in Company | RNS | |
| 11/06/21 | 11:35:06 | 11 Jun 2021 | Holding(s) in Company | RNS | |
| 25/05/21 | 07:00:03 | 25 May 2021 | Half yearly report to 31 March 2021 | RNS | |
| 20/05/21 | 07:00:07 | 20 May 2021 | Phase II Alzheimer’s disease contract award | RNS | |
| 19/05/21 | 07:00:05 | 19 May 2021 | Contract win for new neuroinflammatory disorder | RNS | |
| 11/05/21 | 07:00:04 | 11 May 2021 | Notice of results | RNS | |
| 28/04/21 | 07:00:04 | 28 Apr 2021 | Contract win for new stroke study | RNS | |
| 26/04/21 | 07:00:06 | 26 Apr 2021 | Trading update | RNS | |
| 19/04/21 | 08:21:03 | 19 Apr 2021 | Holding(s) in Company | RNS | |
| 12/04/21 | 16:00:01 | 12 Apr 2021 | Holding(s) in Company | RNS | |
| 01/04/21 | 07:00:09 | 1 Apr 2021 | Holding(s) in Company | RNS | |
| 25/03/21 | 09:14:39 | 25 Mar 2021 | PDMR Transaction | RNS | |
| 24/03/21 | 09:05:37 | 24 Mar 2021 | Second Price Monitoring Extn | RNS | |
| 24/03/21 | 09:00:17 | 24 Mar 2021 | Price Monitoring Extension | RNS | |
| 23/03/21 | 16:40:50 | 23 Mar 2021 | Second Price Monitoring Extn | RNS | |
| 23/03/21 | 16:35:55 | 23 Mar 2021 | Price Monitoring Extension | RNS | |
| 23/03/21 | 15:05:21 | 23 Mar 2021 | Huntington’s disease Phase III contract updates | RNS | |
| 15/03/21 | 16:41:08 | 15 Mar 2021 | Second Price Monitoring Extn | RNS | |
| 15/03/21 | 16:35:32 | 15 Mar 2021 | Price Monitoring Extension | RNS | |
| 15/03/21 | 14:06:16 | 15 Mar 2021 | Second Price Monitoring Extn | RNS | |
| 15/03/21 | 14:00:30 | 15 Mar 2021 | Price Monitoring Extension | RNS | |
| 15/03/21 | 11:06:32 | 15 Mar 2021 | Second Price Monitoring Extn | RNS | |
| 15/03/21 | 11:01:04 | 15 Mar 2021 | Price Monitoring Extension | RNS | |
| 15/03/21 | 07:00:06 | 15 Mar 2021 | Collaboration with Microsoft | RNS | |
| 10/03/21 | 07:00:06 | 10 Mar 2021 | IXICO chosen for new Phase II AD study | RNS | |
| 02/03/21 | 07:00:02 | 2 Mar 2021 | IXICO selected by Cyclerion for a new AD study | RNS | |
| 01/03/21 | 17:25:01 | 1 Mar 2021 | Exercise of Options; PDMR Dealing | RNS | |
| 01/03/21 | 07:00:10 | 1 Mar 2021 | Conference attendance and presentations | RNS | |
| 29/01/21 | 10:19:00 | 29 Jan 2021 | PDMR Dealing | RNS | |
| 21/01/21 | 11:05:05 | 21 Jan 2021 | Result of AGM | RNS | |
| 07/01/21 | 07:00:03 | 7 Jan 2021 | Issue of Equity | RNS | |
| 24/12/20 | 07:00:02 | 24 Dec 2020 | IXICO secures new contract for £3.4 million | RNS | |
| 14/12/20 | 11:54:22 | 14 Dec 2020 | Holding(s) in Company | RNS | |
| 08/12/20 | 07:00:03 | 8 Dec 2020 | IXICO contract with new large global pharma | RNS | |
| 03/12/20 | 14:06:09 | 3 Dec 2020 | Second Price Monitoring Extn | RNS | |
| 03/12/20 | 14:01:07 | 3 Dec 2020 | Price Monitoring Extension | RNS | |
| 02/12/20 | 07:00:06 | 2 Dec 2020 | Financial Results for the year ended 30 Sept 2020 | RNS | |
| 27/11/20 | 07:00:01 | 27 Nov 2020 | IXICO announces £1.9 million new study award | RNS | |
| 09/11/20 | 07:00:13 | 9 Nov 2020 | Notice of Results | RNS | |
| 03/11/20 | 07:00:05 | 3 Nov 2020 | Additional Alzheimer’s disease contracts | RNS | |
| 22/10/20 | 07:00:05 | 22 Oct 2020 | Further Huntington’s disease contracts | RNS | |
| 19/10/20 | 07:00:08 | 19 Oct 2020 | IXICO to Present at SCA & ARCA Global Conference | RNS | |
| 19/10/20 | 07:00:07 | 19 Oct 2020 | Trading Update for year ended 30 September 2020 | RNS | |
| 16/10/20 | 07:00:03 | 16 Oct 2020 | IXICO and NYU Langone Health sign agreement | RNS | |
| 30/09/20 | 14:05:35 | 30 Sept 2020 | Second Price Monitoring Extn | RNS | |
| 30/09/20 | 14:00:24 | 30 Sept 2020 | Price Monitoring Extension | RNS | |
| 29/09/20 | 07:00:03 | 29 Sept 2020 | >£2m contract extension win - Huntington’s disease | RNS |
| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 08/09/21 | 07:00:06 | 8 Sept 2021 | Phase I MSA contract award worth >$500k | RNS | |
| 06/08/21 | 07:00:03 | 6 Aug 2021 | Trading Update | RNS | |
| 23/06/21 | 15:32:31 | 23 Jun 2021 | Issue of Equity | RNS | |
| 21/06/21 | 14:31:16 | 21 Jun 2021 | Holding(s) in Company | RNS | |
| 11/06/21 | 11:35:06 | 11 Jun 2021 | Holding(s) in Company | RNS | |
| 25/05/21 | 07:00:03 | 25 May 2021 | Half yearly report to 31 March 2021 | RNS | |
| 20/05/21 | 07:00:07 | 20 May 2021 | Phase II Alzheimer’s disease contract award | RNS | |
| 19/05/21 | 07:00:05 | 19 May 2021 | Contract win for new neuroinflammatory disorder | RNS | |
| 11/05/21 | 07:00:04 | 11 May 2021 | Notice of results | RNS | |
| 28/04/21 | 07:00:04 | 28 Apr 2021 | Contract win for new stroke study | RNS | |
| 26/04/21 | 07:00:06 | 26 Apr 2021 | Trading update | RNS | |
| 19/04/21 | 08:21:03 | 19 Apr 2021 | Holding(s) in Company | RNS | |
| 12/04/21 | 16:00:01 | 12 Apr 2021 | Holding(s) in Company | RNS | |
| 01/04/21 | 07:00:09 | 1 Apr 2021 | Holding(s) in Company | RNS | |
| 25/03/21 | 09:14:39 | 25 Mar 2021 | PDMR Transaction | RNS | |
| 24/03/21 | 09:05:37 | 24 Mar 2021 | Second Price Monitoring Extn | RNS | |
| 24/03/21 | 09:00:17 | 24 Mar 2021 | Price Monitoring Extension | RNS | |
| 23/03/21 | 16:40:50 | 23 Mar 2021 | Second Price Monitoring Extn | RNS | |
| 23/03/21 | 16:35:55 | 23 Mar 2021 | Price Monitoring Extension | RNS | |
| 23/03/21 | 15:05:21 | 23 Mar 2021 | Huntington’s disease Phase III contract updates | RNS | |
| 15/03/21 | 16:41:08 | 15 Mar 2021 | Second Price Monitoring Extn | RNS | |
| 15/03/21 | 16:35:32 | 15 Mar 2021 | Price Monitoring Extension | RNS | |
| 15/03/21 | 14:06:16 | 15 Mar 2021 | Second Price Monitoring Extn | RNS | |
| 15/03/21 | 14:00:30 | 15 Mar 2021 | Price Monitoring Extension | RNS | |
| 15/03/21 | 11:06:32 | 15 Mar 2021 | Second Price Monitoring Extn | RNS | |
| 15/03/21 | 11:01:04 | 15 Mar 2021 | Price Monitoring Extension | RNS | |
| 15/03/21 | 07:00:06 | 15 Mar 2021 | Collaboration with Microsoft | RNS | |
| 10/03/21 | 07:00:06 | 10 Mar 2021 | IXICO chosen for new Phase II AD study | RNS | |
| 02/03/21 | 07:00:02 | 2 Mar 2021 | IXICO selected by Cyclerion for a new AD study | RNS | |
| 01/03/21 | 17:25:01 | 1 Mar 2021 | Exercise of Options; PDMR Dealing | RNS | |
| 01/03/21 | 07:00:10 | 1 Mar 2021 | Conference attendance and presentations | RNS | |
| 29/01/21 | 10:19:00 | 29 Jan 2021 | PDMR Dealing | RNS | |
| 21/01/21 | 11:05:05 | 21 Jan 2021 | Result of AGM | RNS | |
| 07/01/21 | 07:00:03 | 7 Jan 2021 | Issue of Equity | RNS | |
| 24/12/20 | 07:00:02 | 24 Dec 2020 | IXICO secures new contract for £3.4 million | RNS | |
| 14/12/20 | 11:54:22 | 14 Dec 2020 | Holding(s) in Company | RNS | |
| 08/12/20 | 07:00:03 | 8 Dec 2020 | IXICO contract with new large global pharma | RNS | |
| 03/12/20 | 14:06:09 | 3 Dec 2020 | Second Price Monitoring Extn | RNS | |
| 03/12/20 | 14:01:07 | 3 Dec 2020 | Price Monitoring Extension | RNS | |
| 02/12/20 | 07:00:06 | 2 Dec 2020 | Financial Results for the year ended 30 Sept 2020 | RNS | |
| 27/11/20 | 07:00:01 | 27 Nov 2020 | IXICO announces £1.9 million new study award | RNS | |
| 09/11/20 | 07:00:13 | 9 Nov 2020 | Notice of Results | RNS | |
| 03/11/20 | 07:00:05 | 3 Nov 2020 | Additional Alzheimer’s disease contracts | RNS | |
| 22/10/20 | 07:00:05 | 22 Oct 2020 | Further Huntington’s disease contracts | RNS | |
| 19/10/20 | 07:00:08 | 19 Oct 2020 | IXICO to Present at SCA & ARCA Global Conference | RNS | |
| 19/10/20 | 07:00:07 | 19 Oct 2020 | Trading Update for year ended 30 September 2020 | RNS | |
| 16/10/20 | 07:00:03 | 16 Oct 2020 | IXICO and NYU Langone Health sign agreement | RNS | |
| 30/09/20 | 14:05:35 | 30 Sept 2020 | Second Price Monitoring Extn | RNS | |
| 30/09/20 | 14:00:24 | 30 Sept 2020 | Price Monitoring Extension | RNS | |
| 29/09/20 | 07:00:03 | 29 Sept 2020 | >£2m contract extension win - Huntington’s disease | RNS |